1.
Orlowski TJ, Hill C, Garcia N, Jiminez V, Phillips C. Alternative Vismodegib Dosing Regimen for Patients with Basal Cell Carcinoma. J of Skin [Internet]. 2023Sep.15 [cited 2025Jan.9];7(5):1001-4. Available from: https://skin.dermsquared.com/skin/article/view/2070